UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000031703
Receipt No. R000036207
Official scientific title of the study Oral Beclometasone dipropionate for for gut GVHD
Date of disclosure of the study information 2018/03/15
Last modified on 2018/09/24 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Oral Beclometasone dipropionate for for gut GVHD
Title of the study (Brief title) BDP for gut GVHD
Region
Japan

Condition
Condition Gut Graft-versus-host disease
Classification by specialty
Pediatrics
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Efficacy and safety for gut GVHD to avoid the side effect of systemic steroid treatment
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Efficacy for upper/lower digestive symptom at four
months after treatment by NIH GVHD response criteria
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 oral beclometasone treatment for four months
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
11 years-old <=
Age-upper limit
11 years-old >=
Gender Male
Key inclusion criteria a pediatric case with steroid dependent gut gVHD
Key exclusion criteria no active cytomegalovirus (CMV) infection and no CMV antigenemia for confirmed endoscopically gut GVHD
Target sample size 1

Research contact person
Name of lead principal investigator Satoru Hamada
Organization University of Ryukyus, hospital
Division name Department of Pediatrics
Address 207 Uehara, Nishihara, Okinawa
TEL 0988953331
Email shamada@med.u-ryukyu.ac.jp

Public contact
Name of contact person Satoru Hamada
Organization University of Ryukyus, hospital
Division name Department of Pediatrics
Address 207 Uehara, Nishihara, Okinawa
TEL 0988953331
Homepage URL
Email shamada@med.u-ryukyu.ac.jp

Sponsor
Institute Department of Pediatrics, University of Ryukyus, hospital
Institute
Department

Funding Source
Organization Department of Pediatrics, University of Ryukyus, hospital
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 03 Month 15 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2018 Year 03 Month 15 Day
Anticipated trial start date
2018 Year 03 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 03 Month 13 Day
Last modified on
2018 Year 09 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036207